Calumenin DNA methylation and gene expression in viral myocarditis

Lin Zhao1, Yu Wang2, Liqun Shao3

  • 1Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University Beijing, P.R. China.

Insights

Viral myocarditis induces apoptosis via endoplasmic reticulum (ER) stress. Calumenin protein alleviates this ER stress-induced apoptosis in viral myocarditis, offering a potential therapeutic target.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Pathology

Background:

  • Inflammatory response in myocardial tissue leads to heart failure, with viral myocarditis lacking specific treatments.
  • Apoptosis intervention is a promising strategy for preventing and treating heart failure.
  • Endoplasmic reticulum (ER) stress is an emerging pathway implicated in apoptosis.

Purpose of the Study:

  • To investigate the role of ER stress in viral myocarditis-induced apoptosis.
  • To identify mechanisms regulating ER stress and apoptosis in viral myocarditis.
  • To evaluate the therapeutic potential of calumenin protein in viral myocarditis.

Main Methods:

  • Induction of viral myocarditis in mice using CVB3 treatment.
  • Analysis of ER stress-related proteins (GRP78, ATF4, CHOP) expression.
  • Investigation of calumenin protein's effect on ER stress-induced apoptosis in vivo.
  • Analysis of calumenin DNA methylation in control and VMC groups.

Main Results:

  • CVB3 treatment increased apoptosis in mice.
  • ER stress markers (GRP78, ATF4, CHOP) were upregulated in viral myocarditis.
  • Calumenin protein demonstrated a protective effect against ER stress-induced apoptosis in viral myocarditis.
  • Downregulation of calumenin expression in viral myocarditis was not associated with DNA methylation changes.

Conclusions:

  • Viral myocarditis induces apoptosis through ER stress.
  • Calumenin protein can mitigate ER stress-induced apoptosis in viral myocarditis.
  • Calumenin represents a potential therapeutic target for viral myocarditis and associated heart failure.

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
129
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
293
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
203